Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $287.98 | 4 | 55.5% |
| Food and Beverage | $231.10 | 8 | 44.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $287.98 | 4 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $99.54 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $39.24 | 2 | $0 (2024) |
| Lilly USA, LLC | $27.81 | 2 | $0 (2018) |
| Theravance Biopharma, Inc. | $24.67 | 1 | $0 (2018) |
| PFIZER INC. | $22.95 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $16.89 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56.13 | 3 | E.R. Squibb & Sons, L.L.C. ($39.24) |
| 2022 | $22.95 | 1 | PFIZER INC. ($22.95) |
| 2019 | $89.98 | 2 | Astellas Pharma US Inc ($89.98) |
| 2018 | $152.02 | 4 | AstraZeneca Pharmaceuticals LP ($99.54) |
| 2017 | $198.00 | 2 | Astellas Pharma US Inc ($198.00) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.82 | General |
| Category: Cardiovascular | ||||||
| 03/04/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: Cardiovascular | ||||||
| 10/27/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/08/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $59.99 | General |
| 05/08/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $29.99 | General |
| 12/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $99.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2018 | Lilly USA, LLC | TRADJENTA (Drug), TRULICITY | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Diabetes | ||||||
| 08/10/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Diabetes | ||||||
| 06/26/2018 | Theravance Biopharma, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Infectious Disease | ||||||
| 05/24/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 05/24/2017 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 308 | 514 | $142,366 | $39,095 |
| 2022 | 6 | 212 | 386 | $64,076 | $26,688 |
| 2021 | 4 | 203 | 351 | $67,563 | $29,618 |
| 2020 | 6 | 226 | 309 | $67,755 | $30,643 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 149 | 330 | $73,688 | $19,990 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 63 | $31,089 | $8,364 | 26.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 88 | 93 | $30,393 | $8,182 | 26.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 28 | $7,196 | $2,559 | 35.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 83 | 227 | $31,780 | $12,793 | 40.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 54 | 56 | $10,584 | $4,620 | 43.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 30 | $10,650 | $4,522 | 42.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 39 | $7,332 | $3,141 | 42.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $2,124 | $928.16 | 43.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 22 | $1,606 | $683.56 | 42.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 66 | 184 | $25,760 | $10,716 | 41.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 61 | 62 | $22,010 | $9,921 | 45.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 52 | $9,776 | $4,524 | 46.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 52 | 53 | $10,017 | $4,457 | 44.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 89 | 91 | $32,305 | $14,695 | 45.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 50 | 122 | $17,080 | $7,115 | 41.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 28 | 28 | $8,036 | $4,047 | 50.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 33 | 36 | $6,804 | $3,019 | 44.4% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2020 | 15 | 21 | $2,100 | $1,166 | 55.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 11 | 11 | $1,430 | $599.30 | 41.9% |
About Taranjit Gill
Taranjit Gill is a Internal Medicine healthcare provider based in Canonsburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2016. The National Provider Identifier (NPI) number assigned to this provider is 1710338587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Taranjit Gill has received a total of $519.08 in payments from pharmaceutical and medical device companies, with $56.13 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Education" ($287.98).
As a Medicare-enrolled provider, Gill has provided services to 949 Medicare beneficiaries, totaling 1,560 services with total Medicare billing of $126,044. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Canonsburg, PA
- Active Since 06/23/2016
- Last Updated 05/04/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710338587
Products in Payments
- FARXIGA (Drug) $99.54
- ELIQUIS (Drug) $62.19
- VIBATIV (Drug) $24.67
- XARELTO (Drug) $16.89
- TRULICITY (Drug) $14.86
- TRADJENTA (Drug) $12.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Canonsburg
Yadavendra Rajawat, Md, MD
Internal Medicine — Payments: $13,457
Nithin Bhandarkar, D.o, D.O
Internal Medicine — Payments: $4,011
Thomas Corkery, Do, DO
Internal Medicine — Payments: $1,094
Dr. Ashok Kumar, M.d, M.D
Internal Medicine — Payments: $498.75
Sukaina Jaffer, Md, MD
Internal Medicine — Payments: $204.21
Lauren Gugliotti
Internal Medicine — Payments: $140.03